|
Hydroxypropyl betacyclodextrins are purified polydisperse products resulting from the controlled reaction of propylene oxide and native betacyclodextrin. Roquette's pharmaceutical grade HPBCD is produced in a purpose build, state of the art manufacturing plant following US FDA and ICH Q7A GMP quality guidelines.
- Pharmacopoeia conformity
- European Pharmacopoeia
- Draft USP monograph
- GMP
- Industrial sites: ISO 9001 certified
- Manufacturing plant compliant with cGMP/FDA and GMP/ICH Q7A quality guidelines
US DMF Type IV n° 9420
Canadian DMF n° 2005-150
- KLEPTOSE® Hydroxypropyl betacyclodextrins (HPBCD) are highly soluble betacyclodextrin derivatives suitable for pharmaceutical as well as cosmetic applications.
- A Pyrogen Free pharmaceutical grade can be produced under cGMP conditions for parental use.
- Roquette has been manufacturing pharmaceutical grade HPBCD for several years. This pharmaceutical grade HPBCD is now directly available to the R & D community under the trade name KLEPTOSE® HPB**.
|
- KLEPTOSE® HP
high molecular substitution
- KLEPTOSE® HP Parenteral Grade
high molecular substitution endotoxin controlled
- KLEPTOSE® HPB Oral Grade
medium molecular substitution
- KLEPTOSE® HPB Parenteral Grade
medium molecular substitution endotoxin controlled
Pharmaceutical:
- Suitable for parenteral use, syrups, solutions and oral suspensions as well as for dry formulations (with possibility of in-situ encapsulation).
- To increase water solubility of poorly soluble drugs.
- To increase bioavailability.
- To improve organoleptic properties of bitter or unpleasant actives.
Cosmetics:
- Suitable for encapsulation of volatile compounds.
- To increase shelf life of expensive flavours.
|